Take the lipstick off this pig. It's fair market value relative to Vivus is $6/share (or less). That's NOT even considering that Vivus is the company that has not one (unlike Arena) but TWO drugs currently on the market, one of which has been approved in Europe.
too bad it isn't a game of how many pegs you have on the board. #$%$ pill is so good they cant keep it on shelves. and diet pill is so good doctors refuse to write generic scrips for it. Good luck, hope you make millions. Either way it wont affect me any... why are you here? Oh right. troll. ignore. I'm on a roll today.